by Commetric | Oct 30, 2023
An estimated 33,000 people walked the halls of the European Society for Medical Oncology’s (ESMO) 2023 gathering. The event – which has a reputation for being the most influential oncology congress – is used by many pharma companies as a...
by Commetric | Oct 2, 2023
Communicating clinical trial results is one of the biggest challenges for PR and comms pros in pharma. Distilling scientific data into comprehensible messages that resonate with diverse audiences, from patients to physicians to investors, requires a meticulous...
by Commetric | Aug 17, 2023
Download Commetric’s comprehensive media evaluation report on mergers and acquisitions (M&A) in the healthcare sector In today’s complex healthcare and media landscape, stakeholder mapping has never been more vital for pharma M&A communications. For...
by Commetric | Aug 17, 2023
Pfizer has long been at the forefront of innovation and growth in the healthcare industry. In its recent M&A activities, the company has provided a roadmap for how to leverage corporate communications to create value and reinforce its brand positioning....
by Commetric | Jun 10, 2023
The 2023 ASCO Annual Meeting presented a multitude of clinical research data on cancer care practices, with a major focus on advancements in breast cancer treatment. Our media analysis found that Novartis’ Kisqali was widely praised for its promise of boosting...
